In Duke University v. Sandoz Inc., the Federal Circuit reversed a $39M jury verdict, holding the patent claim invalid for failing to meet §112’s written description requirement for a claimed chemical
In FMC v. Sharda, the Federal Circuit vacated a TRO, finding that the term “composition” should not include a stability requirement omitted from the final patent.
In Mondis v. LG, the Federal Circuit ruled that the patent's written description failed to support amended claims, invalidating key computer display claims.
The Federal Circuit revived UC Berkeley’s claim to key CRISPR gene editing patents, directing the USPTO to reconsider if its findings predate Broad Institute’s.
